Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

Technology appraisal guidance
Reference number: TA121
Published: 27 June 2007

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive

Appendix B: proposal paper presented to the Institute's Guidance Executive
27 August 2010
(62.24 Kb 18 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 31 December 2010